1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Morton, C.J. Pugh, D.J.R. Campbell, I.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Structure STRUE6 2005 0969-2126 4 705 714 10.1016/S0969-2126(96)00076-7 8805554 Solution structure and peptide binding of the SH3 domain from human Fyn. 1996 UK Embo J. EMJODG 0897 0261-4189 12 2617 Crystal Structure of the SH3 Domain in Human Fyn; Comparison of the Three-Dimensional Structures of SH3 Domains in Tyrosine Kinases and Spectrin 1993 10.2210/pdb1nyf/pdb pdb_00001nyf 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 N-TERMINAL GS FROM EXPRESSION SYSTEM 7554.108 FYN 2.7.1.112 SH3 DOMAIN, RESIDUES 82 - 148 INS(GS-T82) 1 man polymer no no TGVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDSIQAEE TGVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDSIQAEE A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia Escherichia coli sample BL21 9606 Homo sapiens 469008 Escherichia coli BL21(DE3) BL21 (DE3) PGEX database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1996-11-08 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1996-04-22 REL 1 BRUNGER refinement X-PLOR 3.1 n 1 82 A n 2 83 A VAL 84 n 3 VAL 84 A THR 85 n 4 THR 85 A LEU 86 n 5 LEU 86 A PHE 87 n 6 PHE 87 A VAL 88 n 7 VAL 88 A ALA 89 n 8 ALA 89 A LEU 90 n 9 LEU 90 A TYR 91 n 10 TYR 91 A ASP 92 n 11 ASP 92 A TYR 93 n 12 TYR 93 A GLU 94 n 13 GLU 94 A ALA 95 n 14 ALA 95 A ARG 96 n 15 ARG 96 A THR 97 n 16 THR 97 A GLU 98 n 17 GLU 98 A ASP 99 n 18 ASP 99 A ASP 100 n 19 ASP 100 A LEU 101 n 20 LEU 101 A SER 102 n 21 SER 102 A PHE 103 n 22 PHE 103 A HIS 104 n 23 HIS 104 A LYS 105 n 24 LYS 105 A GLY 106 n 25 GLY 106 A GLU 107 n 26 GLU 107 A LYS 108 n 27 LYS 108 A PHE 109 n 28 PHE 109 A GLN 110 n 29 GLN 110 A ILE 111 n 30 ILE 111 A LEU 112 n 31 LEU 112 A ASN 113 n 32 ASN 113 A SER 114 n 33 SER 114 A SER 115 n 34 SER 115 A GLU 116 n 35 GLU 116 A GLY 117 n 36 GLY 117 A ASP 118 n 37 ASP 118 A TRP 119 n 38 TRP 119 A TRP 120 n 39 TRP 120 A GLU 121 n 40 GLU 121 A ALA 122 n 41 ALA 122 A ARG 123 n 42 ARG 123 A SER 124 n 43 SER 124 A LEU 125 n 44 LEU 125 A THR 126 n 45 THR 126 A THR 127 n 46 THR 127 A GLY 128 n 47 GLY 128 A GLU 129 n 48 GLU 129 A THR 130 n 49 THR 130 A GLY 131 n 50 GLY 131 A TYR 132 n 51 TYR 132 A ILE 133 n 52 ILE 133 A PRO 134 n 53 PRO 134 A SER 135 n 54 SER 135 A ASN 136 n 55 ASN 136 A TYR 137 n 56 TYR 137 A VAL 138 n 57 VAL 138 A ALA 139 n 58 ALA 139 A PRO 140 n 59 PRO 140 A VAL 141 n 60 VAL 141 A n 61 142 A n 62 143 A n 63 144 A n 64 145 A n 65 146 A n 66 147 A n 67 148 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O PHE 109 A O PHE 28 A N PHE 87 A N PHE 6 A N VAL 88 A N VAL 7 A O ALA 139 A O ALA 58 A O ASN 113 A O ASN 32 A N GLU 121 A N GLU 40 A N TRP 120 A N TRP 39 A O ILE 133 A O ILE 52 1 A THR 82 A THR 1 1 Y 1 A GLY 83 A GLY 2 1 Y 1 A ASP 142 A ASP 61 1 Y 1 A SER 143 A SER 62 1 Y 1 A ILE 144 A ILE 63 1 Y 1 A GLN 145 A GLN 64 1 Y 1 A ALA 146 A ALA 65 1 Y 1 A GLU 147 A GLU 66 1 Y 1 A GLU 148 A GLU 67 1 Y 1 A ARG 96 0.311 SIDE CHAIN 1 A ARG 123 0.091 SIDE CHAIN 1 A PHE 103 -165.19 -169.19 1 A SER 114 -95.97 -72.58 1 A GLU 116 40.39 -162.58 1 A ASP 118 170.59 -31.03 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE, MINIMIZED AVERAGE (PROBMAP) STRUCTURE 1 Y N A PRO 134 A PRO 53 HELX_P A TYR 137 A TYR 56 5 HA 4 PHOSPHOTRANSFERASE SH3 DOMAIN, POLYPROLINE-BINDING, PHOSPHOTRANSFERASE FYN_HUMAN UNP 1 1 P06241 GCVQCKDKEATKLTEERDGSLNQSSGYRYGTDPTPQHYPSFGVTSIPNYNNFHAAGGQGLTVFGGVNSSSHTGTLRTRGG TGVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDSIQAEEWYFGKLGRKDAER QLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGYYITTRAQFETLQQLVQHYSERAAGLCCR LVVPCHKGMPRLTDLSVKTKDVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKL KHDKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNG LICKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER GYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPGENL 81 147 1NYF 82 148 P06241 A 1 1 67 3 3 anti-parallel anti-parallel anti-parallel anti-parallel A LYS 108 A LYS 27 A LEU 112 A LEU 31 A LEU 86 A LEU 5 A ALA 89 A ALA 8 A VAL 138 A VAL 57 A PRO 140 A PRO 59 A ASN 113 A ASN 32 A SER 114 A SER 33 A TRP 119 A TRP 38 A SER 124 A SER 43 A THR 130 A THR 49 A ILE 133 A ILE 52 1 P 1